Canada markets close in 6 hours 1 minute

Johnson & Johnson (JNJ)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
165.24-1.35 (-0.81%)
As of 9:59AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close166.59
Bid165.66 x 800
Ask165.68 x 1200
Day's Range165.01 - 166.19
52 Week Range133.65 - 173.65
Avg. Volume8,300,398
Market Cap435.016B
Beta (5Y Monthly)N/A
PE Ratio (TTM)29.19
EPS (TTM)5.66
Earnings DateJul. 21, 2021
Forward Dividend & Yield4.24 (2.55%)
Ex-Dividend DateMay 24, 2021
1y Target Est185.88
  • Editor's Pick
    Yahoo Finance Video

    Pfizer identifies fake COVID-19 shots abroad

    Emergency Medicine Physician Dr. Hiral Tipirneni joined Yahoo Finance Live to break down how Pfizer indentified fake COVID-19 shots abroad and what this means for vaccine rollout.

  • Editor's Pick
    Yahoo Finance Video

    EU says J&J vaccine benefits outweigh risks, Pfizer finds fake COVID-19 shots 

    European regulators find a possible blood clot link with the Johnson & Johnson vaccine, but say its benefits outweigh the risks. Meanwhile, Pfizer identifies fake COVID-19 shots abroad as criminals exploit vaccine demand. Anjalee Khemlani breaks down the latest on the vaccine front.

  • Reuters

    India to expand vaccinations but supplies tight, imports delayed

    Under fire for his handling of the world's worst COVID-19 surge, Indian Prime Minister Narendra Modi has opened vaccinations for all adults from next month, but supplies are already running short. Public forecasts by its only two vaccine producers show their total monthly output of 70-80 million doses will increase only in two months or more, though the number of people eligible for vaccines will double to an estimated 800 million from May 1. India could start receiving the Sputnik V vaccine only by end-May, its local distributor Dr. Reddy's Laboratories told Reuters, at least a month later than New Delhi had expected.